D-1484-2014 Class III Terminated
FDA drug recall D-1484-2014 was initiated by Novel Laboratories, Inc. on Jun 20, 2014 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specification; 12-month stability time point The recall status is terminated (terminated Jun 29, 2015). Affected quantity: 25,776 containers.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 3, 2014
- Initiation Date
- Jun 20, 2014
- Termination Date
- Jun 29, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,776 containers
Product description
Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.
Reason for recall
Failed Impurity/Degradation Specification; 12-month stability time point
Distribution pattern
Nationwide
Code information
Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1484-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026